You are here: Industry Insights > pharmacy

News List

Developing a new radioactive marker for cancer diagnosis and detection europeanpharmaceuticalreview
April 22, 2019
Scientists are conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer…
Pharmacy benefit managers next up to testify in US Senate hearings on drug pricing firstwordpharma
March 13, 2019
The US Senate Committee on Finance asked executives from five pharmacy benefit manager (PBMs), including CVS Caremark and UnitedHealth's OptumRx unit, to testify at a hearing on April 3 on drug pricing in the country.
PCMA Releases Statement on Senate Finance Committee Hearing on Drug Prices americanpharmaceuticalreview
February 27, 2019
Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Finance Committee hearing, "Drug Pricing in America: A Prescription for Change, Part II:"....
Actelion inks $360M deal to wrap DOJ kickbacks probe fiercepharma
December 10, 2018
An industrywide probe of pharma's charitable contributions has spawned multimillion-dollar kickback settlements, and Actelion is the latest to make a deal with the feds.
OWC Pharmaceutical Research Corp. Completes First Part of Cannabis-Based Ointment Safety Study pharmafocusasia
December 03, 2018
OWC Pharmaceutical Research Corp., a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders...
X4 Pharmaceuticals Presents Additional Positive Phase 2 Results for X4P-001 in WHIM Syndrome, Continues on Path to Initiation of Phase 3 Trial pharmafocusasia
December 03, 2018
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 allosteric antagonist drugs to improve immune cell trafficking to treat rare diseases and cancer...
In swap for faster UK launches, pharma caps sales growth at 2% fiercepharma
November 27, 2018
How much are pharma companies willing to pay in exchange for a faster trip to market in the U.K.? As it turns out, a cap of 2% on total branded-drug sales growth should do. And that’s a deal the industry is billing as a big savings for the government next
People with diabetes want real families in ads fiercepharma
November 27, 2018
Older Americans with diabetes see advertising differently than their peers. That’s according to a new YouGov survey that found 39% of people with diabetes aged 50 and older want to see more ads with “families like mine,” compared with 33% of those in the
Cosmo wins FDA green light to challenge Bausch's Xifaxan fiercepharma
November 26, 2018
Bausch Health has yet to fully recover from its tainted past, and a new threat in the form of a rival to its top-seller Xifaxan could pile more pressure on the drugmaker.
The blockchain revolution and what it means for pharma pharmafile
November 20, 2018
Shaun McVicar, Global Head of Pharmaceuticals, and Solicitor Marine Giral, , of law firm Herbert Smith Freehills, delve into the much-talked about technology, which looks set to be a game-changer in the handling and exchange of data.

Previous page 1 2 3 Next page